Latest News about LLY
Recent news which mentions LLY
REITs Q1 Earnings Begin On Solid Note
April 23, 2024
From Benzinga
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
From Motley Fool
From InvestorPlace
Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires Manufacturing Facility From Nexus Pharma
April 22, 2024
From Benzinga
7 High-Flying Stocks That Are Majorly Overdue for a Pullback
April 22, 2024
From InvestorPlace
Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending
April 22, 2024
From Benzinga
3 Relatively Safe Growth Stocks You Can Buy and Hold
April 20, 2024
From Motley Fool
Exploring The Competitive Space: Eli Lilly and Co Versus Industry Peers In Pharmaceuticals
April 19, 2024
From Benzinga
Strong Buy Alert: 7 No-Brainer Stocks to Scoop Up Now
April 19, 2024
From InvestorPlace
Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025
April 18, 2024
From Benzinga
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 15 Years
April 18, 2024
From Benzinga
Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.
April 18, 2024
From InvestorPlace
From Motley Fool
From Motley Fool
Eli Lilly's Famed Weight Loss Drug Zepbound Works As Sleep Apnea Treatment, Successful Late-Stage Studies Show
April 17, 2024
From Benzinga
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
April 17, 2024
From InvestorPlace
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
April 16, 2024
From Benzinga
From InvestorPlace
BTIG Research Predicts Over 118% Rally for These 3 Stocks
April 15, 2024
Tags
NASDAQ:TBPH,NASDAQ:ANAB,NASDAQ:BTDR,NYSE:LLY,NASDAQ:VTRS,NYSE:BRK/A,NYSE:BRK/B,NASDAQ:SMCI
ANAB
BTDR
From InvestorPlace
From Motley Fool
Better Growth Play: Merck or The Vanguard Growth Index Fund?
April 15, 2024
From Motley Fool
3 Magnificent Stocks That Could Double or More by 2030
April 13, 2024
From Motley Fool
This Vanguard ETF Has Skyrocketed 40% in 12 Months. Is It a No-Brainer Buy Right Now?
April 13, 2024
From Motley Fool
Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week
April 12, 2024
From Motley Fool
Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating
April 12, 2024
From Benzinga
Eli Lilly Suffers Legal Loss For Its Popular Weight Loss/Diabetes Drug In Lawsuit Against Florida Compounding Pharmacy
April 12, 2024
From Benzinga
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
April 12, 2024
From Benzinga
7 A-Rated Aggressive Biotech Stocks to Bet On in 2024
April 12, 2024
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.